Chugai Pharmaceutical Co., Ltd. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CHGCY Over the counter 2834 www.chugai-pharm.co.jp

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Chugai Pharmaceutical Co., Ltd.

Gero Reaches $34M in Equity Funding to Turn the Physics of Aging Into Medicines - Jun 17th, 2026 6:00 am
Immune Thrombocytopenia Market Forecast Signals Steady Growth During the Forecast Period (2026-2036) Backed by Pipeline Advancements | DelveInsight - May 28th, 2026 8:01 am
Major Asian Stock Markets Fall Amid Renewed Middle East Tensions - May 26th, 2026 4:40 am
Sarepta Stock Slumps. Why an Earnings Beat Wasn’t Enough for the S&P 500 Loser. - May 7th, 2026 6:59 am
Earnings Season, Tehran Proposal Lift Asian Stock Markets - Apr 27th, 2026 4:37 am
Is Chugai Pharmaceutical (TSE:4519) Still Attractively Priced After Its Strong Multi Year Run - Apr 13th, 2026 5:05 pm
Mitsubishi Electric Announces Director Candidates - Mar 30th, 2026 1:30 am
Rani Therapeutics Q4 Earnings Call Highlights - Mar 26th, 2026 3:48 pm
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update - Mar 26th, 2026 2:05 pm
Roche stops work on experimental SMA drug - Mar 20th, 2026 5:52 am
Why Sarepta Therapeutics (SRPT) Is Down 11.2% After CEO Retirement Plan And Japan Gene Therapy Launch - And What's Next - Feb 28th, 2026 9:14 pm
Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan - Feb 24th, 2026 7:07 am
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer - Jan 28th, 2026 5:00 am
Assessing Chugai Pharmaceutical (TSE:4519) Valuation Following Strong Share Price Gains - Nov 11th, 2025 3:12 pm
RANI: Third Quarter Results - Nov 10th, 2025 10:45 am
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update - Nov 6th, 2025 2:30 pm
Chugai acquires Renalys, enhancing its kidney disease portfolio - Oct 27th, 2025 4:58 am
H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential - Oct 26th, 2025 4:05 am
Chugai Pharmaceutical (TSE:4519): Valuation Discount and Margin Dip Set Stage for Earnings Season - Oct 25th, 2025 3:07 pm
Chugai buys a kidney biotech; ICER targets rising launch prices - Oct 24th, 2025 2:58 am